Exagen (XGN) Current Assets (2018 - 2026)

Exagen (XGN) has reported Current Assets for 9 consecutive years, with $43.6 million the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $43.6 million, up 34.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.6 million (up 34.08% YoY), and the FY2025 annual result was $48.9 million, up 34.12% from the prior year.
• Current Assets was $43.6 million for Q1 2026 at Exagen, down from $48.9 million in the prior quarter.
• Over five years, Current Assets peaked at $103.6 million in Q1 2022 and troughed at $32.5 million in Q1 2025.
• Average Current Assets over 5 years is $55.5 million, with a median of $48.9 million recorded in 2023.
• Year-over-year, Current Assets plunged 41.85% in 2023 and soared 47.9% in 2025.
• Over 5 years, Current Assets stood at $72.6 million in 2022, then sank by 34.11% to $47.8 million in 2023, then fell by 23.8% to $36.5 million in 2024, then jumped by 34.12% to $48.9 million in 2025, then decreased by 10.86% to $43.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $43.6 million in Q1 2026, $48.9 million in Q4 2025, and $52.6 million in Q3 2025.